PPDI Financial Facts

Selling, general and administrative expenses: 107.58M
Dividends declared per common share: 0.15
See Full Income Statement

Accrued pension liability: 11.86M
Total liabilities: 750.25M
See Full Balance Sheet

Pharmaceutical Product Development Inc. (PPDI) Earnings

  |   Expand Research on PPDI
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +2.5% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +8.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/26/11 Q111 $0.41$0.38 +$0.03$376.2M$370.79M N/A Details
4/26/11 Q111 $0.32$0.33 -$0.01$383.2M$356.33M N/A Details
2/8/11 Q410 $0.40$0.38 +$0.02$388.5M$353.74M N/A Details
10/26/10 Q310 $0.32$0.32 $0.00N/AN/A N/A Details